NPI: 1710107016 · EUGENE, OR 97401 · 207RR0500X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 977 | $45K |
| 2019 | 917 | $34K |
| 2020 | 974 | $47K |
| 2021 | 1,965 | $91K |
| 2022 | 2,355 | $237K |
| 2023 | 3,162 | $329K |
| 2024 | 1,988 | $173K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q5104 | Injection, renflexis | 561 | 257 | $294K |
| 99214 | 3,422 | 2,948 | $196K | |
| J1602 | Golimumab for iv use 1mg | 124 | 68 | $104K |
| 96413 | 1,762 | 1,370 | $99K | |
| Q5103 | Injection, inflectra | 62 | 51 | $83K |
| 99213 | 1,935 | 1,579 | $71K | |
| 99204 | 768 | 689 | $70K | |
| 96415 | 1,112 | 858 | $18K | |
| 96375 | 721 | 548 | $11K | |
| 96365 | 204 | 164 | $5K | |
| J2920 | Methylprednisolone injection | 595 | 442 | $2K |
| J1200 | Diphenhydramine hcl injectio | 752 | 417 | $440.10 |
| 36415 | 206 | 168 | $183.38 | |
| J2919 | Inj, methylpred sod succ 5mg | 51 | 35 | $76.89 |
| J7050 | Normal saline solution infus | 63 | 43 | $13.92 |